Recent studies have shown that CD47, the ligand for SIRPα, is a prognostic factor in breast cancer and its expression correlates with SIRPα expression in bone marrow and peripheral blood of breast cancer patients [32], [45]. This evidence concerns the gene SIRPA and breast cancer.